GL1X · GenesisL1 explorer

MolNFT v1 · #181224 · protein

T4 lysozyme mutant L99A in complex with 3-butylpyridine

7LOG: “T4 lysozyme mutant L99A in complex with 3-butylpyridine”. X-ray diffraction, 1 ligand (Y8J), 2 pockets (best druggability 0.75). MolNFT v1 #181224 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
7LOG
Type
protein
Length
161 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Lysozyme
EC
3.2.1.17
UniProt
D9IEF7
Ligands
Y8J
Pockets
2 · best druggability 0.75

Structure

x-ray diffraction · 1 distinct chain · 65% helix, 9% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ALysozyme (EC 3.2.1.17)protein16165% helix, 9% strandD9IEF7

Ligands and binding sites

  • Y8J · 3-butylpyridine · ligand · chains A
  • BME · Beta-mercaptoethanol · additive · 2 copies · chains A
  • TRS · 2-amino-2-hydroxymethyl-propane-1,3-diol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1690.750.9816Y8J
22630.540.7629TRS

Compared structures

  • 7LOG · T4 lysozyme mutant L99A in complex with 3-butylpyridine · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.